A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Clinical trial NCT05410145 · RECRUITING
Trial details
- NCT number
- NCT05410145
- Sponsor
- D3 Bio (Wuxi) Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2027-04-01
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.